Venneos GmbH

About:

Venneos develops and markets the ‘CAN-Q‘, a silicon-chip-based imaging system for the label-free analysis of biological cells

Website: http://www.venneos.com/

Top Investors: HTGF | High-Tech Gruenderfonds, Max Planck Society

Description:

Venneos GmbH is a German high-tech startup based in Stuttgart. Founded in 2014 as a spin-off from Max Planck Society, it develops and markets the ‘CAN-Q‘, a silicon-chip-based imaging system for the label-free analysis of biological cells. Venneos’ products build upon the innovative technology ‘CAN-Spectroscopy’ that allows customers to detect cellular changes for example in the area of cell adhesion which remain invisible with other technologies.undation of modern computers and approximately 80% of all new technologies are based on it.